{"podcast":{"title":"Minneapolis News Today | 2 Min News | The Daily News Now!","slug":"minneapolis-news-today-2-min-news-the-daily-news-now-7564425","podcast_index_feed_id":7564425,"rss_url":"https://feeds.fastcast.ai/the-minneapolis-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-minneapolis-daily-news-now.jpg","author":"The Daily News Now!","episode_count":608,"summary":"Hosted by Corey with the Story, Minneapolis News Today delivers fast, focused daily updates on the stories shaping Minneapolis—from local news and business to culture, sports, and community developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local news to every city in the world and keeping communities connected. Minneapolis News Today is your daily snapshot of what’s happening in your city. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-09-18T10:18:32.458564+00:00","page_url":"https://stenobird.com/podcast/minneapolis-news-today-2-min-news-the-daily-news-now-7564425"},"episode":{"title":"GLP-1 Drugs Could Help Veterans with Alcohol Use | Minneapolis News","slug":"glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news","published_at":"2026-08-01T05:03:09+00:00","page_url":"https://stenobird.com/podcast/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news","show_page_url":"https://stenobird.com/podcast/minneapolis-news-today-2-min-news-the-daily-news-now-7564425","url":"https://sources.thednn.ai/1f1e04df3d62a93b","audio_url":"https://api.fastcast.ai/audio/c1a2c42a-d0f4-49a3-834d-659269897736.mp3","summary":"Veterans battling alcohol use disorder may soon have a new weapon: GLP-1 drugs like semaglutide, originally used for weight loss. In a groundbreaking clinical trial across 18 VA sites—including Minneapolis—researchers are testing whether these medications can help thousands of veterans struggling with addiction. Led by Dr. Eric Dieperink, the 24-week study randomly assigns participants to either the drug or placebo, aiming to add a powerful new tool to existing treatments. With limited options and rising need, this research could unlock transformative hope for a community in crisis. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/1f1e04df3d62a93b","meta_description":"Veterans battling alcohol use disorder may soon have a new weapon: GLP-1 drugs like semaglutide, originally used for weight loss. In a groundbreaking clin…","key_points":[],"chapters":[],"topics":[],"duration_seconds":98,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/episodes/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}